Search results
Results From The WOW.Com Content Network
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department ...
Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro. ... Price Action: MRNA stock is down 1.04% at $41.40 at the last check on ...
On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...
Monday, Moderna, Inc.’s (NASDAQ:MRNA) manufacturing facility in Laval, Quebec, received a Drug Establishment License (DEL) from Health Canada. This certification affirms the facility’s ...
Moderna held its annual R&D day this week. Moderna's (NASDAQ: MRNA) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand ...
Moderna (MRNA) closed at $222.89 in the latest trading session, marking a +0.68% move from the prior day.
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so.The biggest question for investors, then, is whether ...
Moderna (MRNA) closed at $122.15 in the latest trading session, marking a -0.07% move from the prior day. Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Skip to main content